Where the Money Goes

You are here

Co-Funded Projects

Alex's Lemonade Stand Foundation is proud to partner with nearly 20 different childhood cancer charities to bring us closer to cures. Together, we are supporting the most cutting-edge research in the fight against childhood cancer. View projects supported in collaboration with our charity partners below!

Co-funder

Project Title	Institutions	Co-Funder(s)
Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma	University of Virginia, School of Medicine	I Care I Cure, The Brian Morden Foundation
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma	Children’s Hospital Los Angeles	Northwestern Mutual Foundation
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma	Virginia Commonwealth University	Cure4Cam Childhood Cancer Foundation, I Care I Cure
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma	Virginia Commonwealth University	Cure4Cam Childhood Cancer Foundation, I Care I Cure
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy	University of North Carolina	Cure4Cam Childhood Cancer Foundation, I Care I Cure
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy	University of North Carolina	Cure4Cam Childhood Cancer Foundation, I Care I Cure
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma	Children’s Hospital Los Angeles	Cure4Cam Childhood Cancer Foundation, Flashes of Hope
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma	Children’s Hospital Los Angeles	Cure4Cam Childhood Cancer Foundation, Flashes of Hope
Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb	University of Wisconsin - Madison	Northwestern Mutual Foundation
Optimizing Bispecific Antibody Therapy for Acute Leukemias	Fred Hutchinson Cancer Research Center	Cure4Cam Childhood Cancer Foundation

Pages